Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Thoracic 5Gastrointestinal 5Sarcoma 4Genitourinary 4Dermatologic 3Other solid neoplasm 2Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 307Cyclophosphamide 234Cytarabine 202Azacitidine 190fludarabine 183Specimen Handling 136Biopsy 103fludarabine phosphate 98Methotrexate 83Rituximab 79Daunorubicin 78Dexamethasone 77Vincristine 70Whole-Body Irradiation 65Mycophenolic Acid 60Decitabine 58Tacrolimus 56Etoposide 53ibrutinib 52blinatumomab 52obinutuzumab 51Granulocyte Colony-Stimulating Factor 51Busulfan 50Prednisone 48Melphalan 48acalabrutinib 47Injections 47Stem Cell Transplantation 45Idarubicin 45Magnetic Resonance Spectroscopy 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cryosurgery × Other hematologic neoplasm × 1 year × Clear all
NCT03035331 2026-05-04

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Mayo Clinic

Phase 1/2 Completed
11 enrolled 12 charts
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡